Session 3: Medication-Assisted Treatment for Substance Use Disorders
Moderator: Dr. Gilberto Gerra, Chief, Drug Prevention and Health Branch, UNODC
• WHO Guidelines and Tools on Diagnosis and Management of Substance Use Disorders, Dr. Vladimir Poznyak, World Health Organization (WHO)
• (0:21:11) Using Medication-Assisted Treatment to Treat Opioid Use Disorder: Learning from Past Experience to Guide Policy, Mark Parrino, M.P.A., President, American Association for the Treatment of Opioid Dependence, Inc.
• (0:38:30) Naltrexone for Opioid Use Disorders: Oral, Implantable and Injectable, Evgeny Krupitsky, M.D., Ph.D., D.Med.Sci, Chief, Department of Addictive Disorders, Bekhterev State Psychoneurological Research Institute
• (0:52:47) Promising Pharmacological Treatments of Stimulant Use Disorder: Time for Translation to Clinical Practice, Dr. Adam Bisaga, Professor of Psychiatry, Columbia University Medical Center & Research Scientist at the New York State Psychiatric Institute
• (1:11:26) Is Agonist Opioid Treatment Long Enough? The Role of Craving and Psychopathology, Dr. Icro Maremmani, Professor of Drug Addiction Medicine at the School of Psychiatry of the University of Pisa, Italy
source
